A comprehensive assessment of the clotting process should include anti-Xa levels for patients on heparin or low molecular weight heparin, and prothrombin time (PT) and international normalized ratio (INR) for overall coagulation status, although interpretation should be cautious due to the interference of lupus anticoagulant. This evidence concerns the gene F2 and systemic lupus erythematosus.